336 related articles for article (PubMed ID: 16684430)
1. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
Sunder TR; McKee JR; Hammer AE; Vuongc A
Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
3. Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation.
McKee JR; Sunder TR; FineSmith R; Vuong A; Varner JA; Hammer AE; Barrett PS
Epilepsy Behav; 2003 Aug; 4(4):386-94. PubMed ID: 12899858
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
Gidal BE; Walker JK; Lott RS; Shaw R; Speth J; Marty KJ; Rutecki P
Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive lamotrigine for refractory epilepsy in adolescents with mental retardation.
McKee JR; Sunder TR; Vuong A; Hammer AE
J Child Neurol; 2006 May; 21(5):372-9. PubMed ID: 16901441
[TBL] [Abstract][Full Text] [Related]
6. Lamotrigine extended-release as adjunctive therapy for partial seizures.
Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.
Biton V; Sackellares JC; Vuong A; Hammer AE; Barrett PS; Messenheimer JA
Neurology; 2005 Dec; 65(11):1737-43. PubMed ID: 16344515
[TBL] [Abstract][Full Text] [Related]
8. Effect of lamotrigine on depressive symptoms in adult patients with epilepsy.
Ettinger AB; Kustra RP; Hammer AE
Epilepsy Behav; 2007 Feb; 10(1):148-54. PubMed ID: 17071141
[TBL] [Abstract][Full Text] [Related]
9. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
Evans BK; Kustra RP; Hammer AE
Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
[TBL] [Abstract][Full Text] [Related]
10. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy.
Labiner DM; Ettinger AB; Fakhoury TA; Chung SS; Shneker B; Tatum Iv WO; Mitchell Miller J; Vuong A; Hammer AE; Messenheimer JA
Epilepsia; 2009 Mar; 50(3):434-42. PubMed ID: 19016830
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy.
Wechsler RT; Leroy R; Van Cott A; Hammer AE; Vuong A; Huffman R; VanLandingham K; Messenheimer JA
Epilepsy Res; 2014 Aug; 108(6):1128-36. PubMed ID: 24888248
[TBL] [Abstract][Full Text] [Related]
12. Lamotrigine therapy in patients requiring a change in antiepileptic drug regimen.
Kustra RP; Meador KJ; Evans BK; Leschek-Gelman LM; Groenke DA; Hammer AE; Nanry KP; Messenheimer JA;
Seizure; 2005 Jun; 14(4):254-61. PubMed ID: 15911360
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
[TBL] [Abstract][Full Text] [Related]
14. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.
Blum D; Meador K; Biton V; Fakhoury T; Shneker B; Chung S; Mills K; Hammer A; Isojärvi J
Neurology; 2006 Aug; 67(3):400-6. PubMed ID: 16894098
[TBL] [Abstract][Full Text] [Related]
15. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
[TBL] [Abstract][Full Text] [Related]
17. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.
Motte J; Trevathan E; Arvidsson JF; Barrera MN; Mullens EL; Manasco P
N Engl J Med; 1997 Dec; 337(25):1807-12. PubMed ID: 9400037
[TBL] [Abstract][Full Text] [Related]
18. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.
Uvebrant P; Bauzienè R
Neuropediatrics; 1994 Dec; 25(6):284-9. PubMed ID: 7770124
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy.
Goa KL; Ross SR; Chrisp P
Drugs; 1993 Jul; 46(1):152-76. PubMed ID: 7691504
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study.
Biton V; Di Memmo J; Shukla R; Lee YY; Poverennova I; Demchenko V; Saiers J; Adams B; Hammer A; Vuong A; Messenheimer J
Epilepsy Behav; 2010 Nov; 19(3):352-8. PubMed ID: 20937567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
